Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Colorectal Cancer (Locally Advanced or Metastatic) · Prostate Cancer - Recurrent · Pancreatic Ductal Adenocarcinoma (PDAC) · Ovarian Cancer · Glioblastoma · Melanoma (Skin Cancer) · Acute Myeloid Leukemia (AML) · Non Hodgkin Lymphoma · Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma · Liver Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
District One Hospital, Beijing, Beijing Municipality, China